Researchers are using 3D bioprinting to create artificial blood vessels that can be used to test new custom-tailored drugs and study why brain tumors are so resilient.

We are pleased to share that our poster presentation at the 2026 MPS World Summit in Washington, DC has been successfully completed. We presented our work entitled “A Reconfigurable Multi-Organ-on-a-Chip for Stepwise Analysis of Intestine–Liver and Liver–Brain Interactions in NAFLD-Associated Alzheimer’s Disease.” In this study, we developed a reconfigurable multi-organ-on-a-chip platform that enables stepwise switching from intestine–liver interaction to liver–brain interaction within a low-volume closed-loop microfluidic system.

We are pleased to announce that our work has been accepted for poster presentation at the 2026 MPS World Summit. Title: A Reconfigurable Multi-Organ-on-a-Chip for Stepwise Analysis of Intestine–Liver and Liver–Brain Interactions in NAFLD-Associated Alzheimer’s DiseaseAuthors: Mahiro Yamamoto, Kenichiro Kamei, Yoshikazu Hirai This study presents a reconfigurable multi-organ-on-a-chip designed to investigate sequential organ-axis interactions involved in NAFLD-associated Alzheimer’s disease.